Advances in studies on cancer treatment by anti-human epidermal growth factor receptor 3 monoclonal antibody

doi:10.3760/cma.j.issn.1673-4211.2019.06.007

PDF(730 KB)

International Journal of Biologicals ›› 2019, Vol. 42 ›› Issue (6) : 289-293. DOI: 10.3760/cma.j.issn.1673-4211.2019.06.007

Advances in studies on cancer treatment by anti-human epidermal growth factor receptor 3 monoclonal antibody

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 42(6): 289-293 https://doi.org/10.3760/cma.j.issn.1673-4211.2019.06.007

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(730 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export